Having trouble viewing this email? View in your browser.
ESCMID Logo

14 August 2018
WEEKLY NEWS

Dear colleagues,

Please find below the latest edition of ESCMID Weekly News.

With kind regards,

ESCMID Executive Office.

 

ESCMID Postgraduate Course in Delhi, India

Don’t miss the course ‘Antifungal Resistance in Candida and Aspergillus: from Clinic to Clinical Laboratory’, to be held in Delhi, India from 19-21 September 2018. Registrations close 17 August 2018.

› Read more
 

CMI highlight: Clofazimine improves clinical outcomes in multidrug-resistant tuberculosis

MDR-TB patients managed in 17 TB specialised hospitals in China between September 2009 and September 2011 were randomly assigned to the treatment groups at enrolment. In the intervention group 100 mg CFZ per day was added to the standardised regimen. The primary outcome was the proportion of patients with successful outcomes. From the 156 patients that were screened, 74 were assigned to the control group and 66 to the CFZ group. Of the 66 cases analysed for clinical outcome in the CFZ group, 36 patients were cured, and 7 completed treatment, yielding a favourable outcome rate of 65.1%. The proportion of patients with favourable outcomes among control regimen was 47.3% (35/74), which was significantly lower than that in the CFZ group (P=0.034, RR=0.661, 95%CI: 0.243-0.949). The addition of clofazimine to the standard regimen improved the treatment of MDR-TB.

› Read more
 

Apply for funding to support study group research projects until 30 August 2018

Also this year, ESCMID study groups can apply to receive funding for their research projects (laboratory investigations, clinical studies, experimental animal studies, or a combination of these). The deadline for submission is 30 August 2018.
Eligible proposals are evaluated by the Scientific Affairs Subcommittee based on scientific and/or technological excellence and on the quality and efficiency of the project’s implementation and budget. Geographic distribution of the partners as well as gender balance will be taken into account. For further information, please consult the website.

› Read more
 

Nominations for the TAE Steering Committee are open until 17 September

In 2018 we are looking for new Trainee Association of ESCMID Steering Committee members with a background in Clinical Microbiology. The vacancies are for a three-year term starting in January 2019 and are to be filled with new members who will be elected in Autumn 2018. You can view the criteria here. The nomination platform is open until 17 September. Don`t miss this chance to be a part of a dynamic and international team of young scientists!

› Read more
 

EiTaF Outbreak News: West Nile fever in Europe

The International Society of Heart and Lung Transplantation is seeking abstracts for its 39th Annual Meeting and Scientific Sessions, scheduled for April 3 - 6, 2019, in Orlando, Florida (USA) at the Loews Meeting Complex. ISHLT is particularly interested in abstracts related to Pulmonary Hypertension and Chronic Thromboembolic Pulmonary Hypertension. The submission fee is $25. Abstract submission deadline is 23 October 2018.

› Read more
ESCMID Executive Office
P.O. Box 214
4010 Basel
Switzerland
Phone +41 61 5080 173
info@escmid.org
www.escmid.org
Follow ESCMID
Visit us on LinkedIn Visit us on YouTube
 
The ESCMID Newsletter is issued on behalf of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) by the ESCMID Executive Office. It contains announcements of ESCMID-related matters and other information of interest to professionals in the infection field.

Tip: To ensure that you receive the ESCMID newsletter in your inbox, add newsletter@escmid.org to your email program’s address book.

You have received this email as a contact of ESCMID or one of its affiliated societies. You can unsubscribe or change your newsletter subscriptions here.